Valneva SE (VALN) stock

VALNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 17, 2026Score 1/30

$5.66−0.10 (-1.74%)

Close on Nov 13, 2026Market cap $491.12MP/E –Yield –

Valneva profit margin

Profit margin (net margin) is net income as a percentage of revenue.

For fiscal 2021 it was -17.6%, against -50.0% the year before.

Period	Period end	Value	Change (pts)
FY2021	Dec 31, 2021	-17.6%	+32.3
FY2020	Dec 31, 2020	-50.0%	−49.3
FY2019	Dec 31, 2019	-0.6%	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is VALN.

Revenue growth-27.2% · median 25.4%

Gross margin16.4% · median 89.0%

Operating margin-80.5% · median -21.2%

Advertisement
300 × 250

See a number that looks wrong?